This clinical trial is focused on studying the effects of a medication called atorvastatin on a heart condition known as Arrhythmogenic Cardiomyopathy (ACM). ACM is a disease that affects the heart muscle, leading to irregular heartbeats and potentially causing heart failure. The trial aims to evaluate whether atorvastatin, a drug commonly used to lower cholesterol, can help reduce or delay the progression of this heart condition.

Participants in the study will be given atorvastatin in the form of film-coated tablets, which are taken orally. The study will also include a group of participants who will receive a placebo. The main goal is to see if atorvastatin can prevent the worsening of the heart’s right ventricle, which is a part of the heart that can be affected by ACM. The study will monitor various health indicators, including heart function and rhythm, using methods like echocardiograms (ECHO) and blood tests.

The trial will take place over a period of time, with regular check-ups to assess the participants’ heart health and any changes in their condition. The study is designed to provide valuable information on whether atorvastatin can be an effective treatment option for people with ACM, potentially improving their quality of life by managing the progression of the disease.